The GEODe™ technology platform represents a breakthrough approach in biotechnology that facilitates the targeting of GPCRs, significantly enhancing the development of therapeutic proteins and antibodies. This platform overcomes traditional barriers in drug development, enabling more effective and safer biologics.

• ·Proprietary technology specifically targeting GPCRs
• ·Streamlined drug development process
• ·Ability to modify disease progression